T45. 1X5A - Adverse effect of antineoplastic and immunosuppressive drugs [initial encounter] | ICD-10-CM.
D84.9D84. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.
Z92. 25 - Personal history of immunosuppression therapy. ICD-10-CM.
When your immune system fails to respond adequately to infection, it's called an immunodeficiency, and you may be immunocompromised. People may also suffer from the opposite condition, an overactive immune system that attacks healthy cells as though they were foreign bodies, and that is called an autoimmune response.
But when you're immunocompromised, your immune system's defenses are low, affecting its ability to fight off infections and diseases. Depending on why your immune system is compromised, this state can be either permanent or temporary. Dr.May 13, 2020
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
G62. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10-CM Code for Anemia due to antineoplastic chemotherapy D64. 81.
Personal history of immunosuppression therapy Z92. 25 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Other long term (current) drug therapy Z79. 899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code D84. 81 for Immunodeficiency due to conditions classified elsewhere is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .